Evaluation of Immune‐enhancing Effects of Ibuprofen in an Immunodeficiency Model

Joseph L. Jorizzo; Randall M. Goldblum; Jerry C. Daniels; Yukinobu Ichikawa; Marlyn P. Langford; Karis M. Fagan

doi:10.1111/j.1365-4362.1985.tb05423.x

Evaluation of Immune‐enhancing Effects of Ibuprofen in an Immunodeficiency Model

Joseph L. Jorizzo, Randall M. Goldblum, Jerry C. Daniels, Yukinobu Ichikawa, Marlyn P. Langford, Karis M. Fagan

Pediatrics

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Abstract: Three children and one adult with chronic mucocutaneous candidosis with documented deficient cellular immunity to Candida antigen were evaluated as a model to study the specific cellular immune‐enhancing potential of the prostaglandin synthetase inhibitor ibuprofen. Oral ibuprofen failed to have any consistent effect during sequential 4‐week on and off cycles on the following parameters: delayed hypersensitivity skin testing; lymphocyte transformation to Candida antigen; T‐cell subsets as determined by monoclonal antibody techniques; production of human immune interferon in response to staphylococcal enterotoxin A (SEA). Two patients showed a trend toward enhanced lymphocyte transformation to PHA while taking ibuprofen. In two patients who were studied 8–10 weeks after discontinuation of oral ketoconazole therapy, clinical recurrence of CMC was not prevented by oral ibuproten therapy.

Original language	English (US)
Pages (from-to)	183-187
Number of pages	5
Journal	International Journal of Dermatology
Volume	24
Issue number	1
DOIs	https://doi.org/10.1111/j.1365-4362.1985.tb05423.x
State	Published - Jan 1985

ASJC Scopus subject areas

Dermatology

Access to Document

10.1111/j.1365-4362.1985.tb05423.x

Cite this

@article{343d97e913174512b46fcbd0e64336ee,

title = "Evaluation of Immune‐enhancing Effects of Ibuprofen in an Immunodeficiency Model",

abstract = "Abstract: Three children and one adult with chronic mucocutaneous candidosis with documented deficient cellular immunity to Candida antigen were evaluated as a model to study the specific cellular immune‐enhancing potential of the prostaglandin synthetase inhibitor ibuprofen. Oral ibuprofen failed to have any consistent effect during sequential 4‐week on and off cycles on the following parameters: delayed hypersensitivity skin testing; lymphocyte transformation to Candida antigen; T‐cell subsets as determined by monoclonal antibody techniques; production of human immune interferon in response to staphylococcal enterotoxin A (SEA). Two patients showed a trend toward enhanced lymphocyte transformation to PHA while taking ibuprofen. In two patients who were studied 8–10 weeks after discontinuation of oral ketoconazole therapy, clinical recurrence of CMC was not prevented by oral ibuproten therapy.",

author = "Jorizzo, {Joseph L.} and Goldblum, {Randall M.} and Daniels, {Jerry C.} and Yukinobu Ichikawa and Langford, {Marlyn P.} and Fagan, {Karis M.}",

year = "1985",

month = jan,

doi = "10.1111/j.1365-4362.1985.tb05423.x",

language = "English (US)",

volume = "24",

pages = "183--187",

journal = "International Journal of Dermatology",

issn = "0011-9059",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Evaluation of Immune‐enhancing Effects of Ibuprofen in an Immunodeficiency Model

AU - Jorizzo, Joseph L.

AU - Goldblum, Randall M.

AU - Daniels, Jerry C.

AU - Ichikawa, Yukinobu

AU - Langford, Marlyn P.

AU - Fagan, Karis M.

PY - 1985/1

Y1 - 1985/1

N2 - Abstract: Three children and one adult with chronic mucocutaneous candidosis with documented deficient cellular immunity to Candida antigen were evaluated as a model to study the specific cellular immune‐enhancing potential of the prostaglandin synthetase inhibitor ibuprofen. Oral ibuprofen failed to have any consistent effect during sequential 4‐week on and off cycles on the following parameters: delayed hypersensitivity skin testing; lymphocyte transformation to Candida antigen; T‐cell subsets as determined by monoclonal antibody techniques; production of human immune interferon in response to staphylococcal enterotoxin A (SEA). Two patients showed a trend toward enhanced lymphocyte transformation to PHA while taking ibuprofen. In two patients who were studied 8–10 weeks after discontinuation of oral ketoconazole therapy, clinical recurrence of CMC was not prevented by oral ibuproten therapy.

AB - Abstract: Three children and one adult with chronic mucocutaneous candidosis with documented deficient cellular immunity to Candida antigen were evaluated as a model to study the specific cellular immune‐enhancing potential of the prostaglandin synthetase inhibitor ibuprofen. Oral ibuprofen failed to have any consistent effect during sequential 4‐week on and off cycles on the following parameters: delayed hypersensitivity skin testing; lymphocyte transformation to Candida antigen; T‐cell subsets as determined by monoclonal antibody techniques; production of human immune interferon in response to staphylococcal enterotoxin A (SEA). Two patients showed a trend toward enhanced lymphocyte transformation to PHA while taking ibuprofen. In two patients who were studied 8–10 weeks after discontinuation of oral ketoconazole therapy, clinical recurrence of CMC was not prevented by oral ibuproten therapy.

UR - http://www.scopus.com/inward/record.url?scp=0021920862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021920862&partnerID=8YFLogxK

U2 - 10.1111/j.1365-4362.1985.tb05423.x

DO - 10.1111/j.1365-4362.1985.tb05423.x

M3 - Article

C2 - 3922905

AN - SCOPUS:0021920862

SN - 0011-9059

VL - 24

SP - 183

EP - 187

JO - International Journal of Dermatology

JF - International Journal of Dermatology

IS - 1

ER -

Evaluation of Immune‐enhancing Effects of Ibuprofen in an Immunodeficiency Model

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this